PortfoliosLab logo
GILD vs. LLY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between GILD and LLY is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.5

Performance

GILD vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Gilead Sciences, Inc. (GILD) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

10,000.00%15,000.00%20,000.00%25,000.00%NovemberDecember2025FebruaryMarchApril
22,887.97%
10,707.50%
GILD
LLY

Key characteristics

Sharpe Ratio

GILD:

2.39

LLY:

0.54

Sortino Ratio

GILD:

3.36

LLY:

1.01

Omega Ratio

GILD:

1.43

LLY:

1.13

Calmar Ratio

GILD:

2.01

LLY:

0.79

Martin Ratio

GILD:

13.25

LLY:

1.61

Ulcer Index

GILD:

4.51%

LLY:

12.05%

Daily Std Dev

GILD:

25.08%

LLY:

36.25%

Max Drawdown

GILD:

-70.82%

LLY:

-68.27%

Current Drawdown

GILD:

-11.51%

LLY:

-7.55%

Fundamentals

Market Cap

GILD:

$132.33B

LLY:

$794.31B

EPS

GILD:

$4.76

LLY:

$11.69

PE Ratio

GILD:

21.67

LLY:

75.67

PEG Ratio

GILD:

0.22

LLY:

1.41

PS Ratio

GILD:

4.61

LLY:

17.63

PB Ratio

GILD:

6.73

LLY:

55.97

Total Revenue (TTM)

GILD:

$22.06B

LLY:

$36.27B

Gross Profit (TTM)

GILD:

$17.36B

LLY:

$29.53B

EBITDA (TTM)

GILD:

$7.98B

LLY:

$12.51B

Returns By Period

In the year-to-date period, GILD achieves a 12.48% return, which is significantly lower than LLY's 14.78% return. Over the past 10 years, GILD has underperformed LLY with an annualized return of 3.59%, while LLY has yielded a comparatively higher 30.96% annualized return.


GILD

YTD

12.48%

1M

-7.19%

6M

17.72%

1Y

63.62%

5Y*

9.61%

10Y*

3.59%

LLY

YTD

14.78%

1M

7.65%

6M

-0.58%

1Y

21.37%

5Y*

42.44%

10Y*

30.96%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

GILD vs. LLY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GILD
The Risk-Adjusted Performance Rank of GILD is 9696
Overall Rank
The Sharpe Ratio Rank of GILD is 9797
Sharpe Ratio Rank
The Sortino Ratio Rank of GILD is 9696
Sortino Ratio Rank
The Omega Ratio Rank of GILD is 9595
Omega Ratio Rank
The Calmar Ratio Rank of GILD is 9494
Calmar Ratio Rank
The Martin Ratio Rank of GILD is 9797
Martin Ratio Rank

LLY
The Risk-Adjusted Performance Rank of LLY is 7171
Overall Rank
The Sharpe Ratio Rank of LLY is 7373
Sharpe Ratio Rank
The Sortino Ratio Rank of LLY is 6767
Sortino Ratio Rank
The Omega Ratio Rank of LLY is 6565
Omega Ratio Rank
The Calmar Ratio Rank of LLY is 8181
Calmar Ratio Rank
The Martin Ratio Rank of LLY is 7171
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

GILD vs. LLY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Gilead Sciences, Inc. (GILD) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for GILD, currently valued at 2.39, compared to the broader market-2.00-1.000.001.002.003.00
GILD: 2.39
LLY: 0.54
The chart of Sortino ratio for GILD, currently valued at 3.36, compared to the broader market-6.00-4.00-2.000.002.004.00
GILD: 3.36
LLY: 1.01
The chart of Omega ratio for GILD, currently valued at 1.43, compared to the broader market0.501.001.502.00
GILD: 1.43
LLY: 1.13
The chart of Calmar ratio for GILD, currently valued at 2.01, compared to the broader market0.001.002.003.004.005.00
GILD: 2.01
LLY: 0.79
The chart of Martin ratio for GILD, currently valued at 13.25, compared to the broader market-5.000.005.0010.0015.0020.00
GILD: 13.25
LLY: 1.61

The current GILD Sharpe Ratio is 2.39, which is higher than the LLY Sharpe Ratio of 0.54. The chart below compares the historical Sharpe Ratios of GILD and LLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00NovemberDecember2025FebruaryMarchApril
2.39
0.54
GILD
LLY

Dividends

GILD vs. LLY - Dividend Comparison

GILD's dividend yield for the trailing twelve months is around 3.00%, more than LLY's 0.61% yield.


TTM20242023202220212020201920182017201620152014
GILD
Gilead Sciences, Inc.
3.00%3.33%3.70%3.40%3.91%4.67%3.88%3.65%2.90%2.57%1.27%0.00%
LLY
Eli Lilly and Company
0.61%0.67%0.78%1.07%1.23%1.75%1.96%1.95%2.46%2.77%2.37%2.84%

Drawdowns

GILD vs. LLY - Drawdown Comparison

The maximum GILD drawdown since its inception was -70.82%, roughly equal to the maximum LLY drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for GILD and LLY. For additional features, visit the drawdowns tool.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-11.51%
-7.55%
GILD
LLY

Volatility

GILD vs. LLY - Volatility Comparison

The current volatility for Gilead Sciences, Inc. (GILD) is 8.79%, while Eli Lilly and Company (LLY) has a volatility of 18.64%. This indicates that GILD experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%NovemberDecember2025FebruaryMarchApril
8.79%
18.64%
GILD
LLY

Financials

GILD vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between Gilead Sciences, Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items